-
FairJourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery with Geneious Biologics
Dec 10, 2018, 12:29 PM by Michael CroftAUCKLAND CITY, NEW ZEALAND - Dec 10, 2018 - AUCKLAND, NZ – December 10, 2018 – Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the companys growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programsFull story -
Rehm Replaces Haussler As GA4GH Vice Chair, Other Changes
Dec 10, 2018, 12:20 PM by Michael CroftFull storyBio-IT World Brief GA4GH announced several changes in leadership. GA4GH Vice Chair David Haussler, Scientific Director of the University of California Santa Cruz Genomics Institute, will be succeeded by Heidi Rehm,an institute member at the Broad Institute of MIT and Harvard and chief genomics officer at Massachusetts General Hospital.
-
10x Genomics Acquires Spatial Genomics Company
Dec 10, 2018, 11:25 AM by Michael CroftBio-IT World Brief 10x Genomics has acquired Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight into understanding disease.Full story -
Qlucore announces partnership with Cambridge Protein Arrays Ltd
Dec 10, 2018, 11:12 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Dec 10, 2018 - The partnership announced today between Qlucore and Cambridge Protein Arrays Ltd (CPA) will strengthen the end-to-end solution for protein analysisFull story -
HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for Cancer
Dec 10, 2018, 09:13 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Dec 10, 2018 - HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, today announced the formation of Victa Biotherapeutics, a joint venture with Vikas PFull story -
10x Genomics Acquires Spatial Transcriptomics
Dec 10, 2018, 08:50 AM by Michael CroftPLEASANTON, CA, UNITED STATES - Dec 10, 2018 - 10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomicsFull story -
Rho Experts Explore Right-to-Try Legislation and Existing Expanded Access Programs in Free Webinar
Dec 7, 2018, 12:04 PM by Michael CroftCHAPEL HILL, NC - Dec 7, 2018 - Rho Experts Explore Right-to-Try Legislation and ExistingExpanded Access Programs in Free Webinar WHAT: The impact of Right-to-Try legislation has been in the news a lot recently, but what does the legislation mean for product sponsors? Rho, a full-service contract research organization (CRO), will explore both Right-to-Try legislation and existing Expanded Access Programs in a new free webinar, including:o Understanding sponsor responsibilities under these programs and when products may be eligibleo Evaluating options such as treatment protocols, treatment INDs, and emergency useo Discussing development risks associated with participation in these programs The webinar, "Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA's Expanded Access," will take place on Tuesday, DecFull story -
A Mature Capital Structure Positions Bio-IT Startups For Success
Dec 6, 2018, 11:45 AM by Michael CroftFull storyBio-IT World Contributed Commentary | By establishing a mature capital structure reflecting a healthy balance of both equity and debt, early-stage bio-IT companies can project long-term strength and vision that helps to favorably position them with their stakeholders.
-
Industry Leaders Join Forces to Discuss Optimizing eConsent for Patient Centricity
Dec 6, 2018, 09:03 AM by Michael CroftPLYMOUTH MEETING, PA - Dec 6, 2018 - Clinical research and technology leaders from across the industry will share their data and expertise at an upcoming webinar hosted by CRF Health, a CRF Bracket company, to discuss how to improve patient centricity through electronic informed consent (eConsent)Full story -
Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research Centers
Dec 5, 2018, 14:45 PM by Michael CroftRANCHO SANTA MARGARITA, CA, UNITED STATES - Dec 4, 2018 - Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research CentersCutting Edge Data Quality Transforms Real-World Clinical Data into aFuture-Proofed, Research-Ready Data Goldmine for Better Patient CareMelissa, a leading provider of global contact data quality and identity verification solutions, today announced advanced artificial intelligence (AI) solutions that combine machine reasoning, natural language processing, and machine learning to tackle one of healthcare's biggest problems: the time and cost of data harmonization and integrationFull story -
Equus Compute Solutions Announces Release of G2660 2U 2xGPU Server
Dec 5, 2018, 13:47 PM by Michael CroftEDINA, MN - Dec 5, 2018 - Equus Compute Solutions announces the release of its new G2660 2U 2xGPU server, ideal for artificial intelligence and deep learning environmentsFull story -
Sekisui XenoTech Announces Creation of Scientific Advisory Board (SAB)
Dec 5, 2018, 11:11 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Dec 5, 2018 - Sekisui XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industryFull story -
GSK Bags Tesaro For $5B As It Leaps Back Into Commercial Oncology, Beefs Up Cancer Drug Pipeline
Dec 5, 2018, 10:39 AM by Michael CroftEndpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.Full story -
OmniTier Debuts CompStor Novos Platform For De Novo Assembly-Based Variant Calling
Dec 5, 2018, 09:20 AM by Michael CroftFull storyBio-IT World News Brief | OmniTier has debuted the CompStor Novos platform for de novo assembly-based variant calling in whole genome sequencing applications.
-
Certara Launches BaseCase Toolkits to Facilitate Pharmaceutical and Medical Device Field Teams’ HCP and Payer Presentations
Dec 5, 2018, 08:14 AM by Michael CroftPRINCETON, NJ - Dec 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentationsFull story -
uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target
Dec 5, 2018, 05:48 AM by Michael CroftEDINBURGH, UK - Dec 5, 2018 - Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research targetFull story -
BOC Sciences Recently Updates Its Metabolites and Impurities Collection
Dec 4, 2018, 01:02 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research communityFull story -
Creative Peptides Released Post-translational Modification for Science Community
Dec 4, 2018, 00:58 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Earlier this October, Creative Peptides, one of the worlds leading peptide manufacturers, has announced a series of peptide modification servicesFull story -
TARGET PharmaSolutions® Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research
Dec 3, 2018, 11:27 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Dec 3, 2018 - TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBDFull story -
Despite CRISPR Baby Controversy, Harvard University Will Begin Gene-Editing Sperm
Nov 30, 2018, 11:22 AM by Michael CroftMIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.Full story